Design and optimization of curcumin loaded nano lipid carrier system using Box-Behnken design

被引:107
作者
Agrawal, Mukta [1 ]
Saraf, Shailendra [2 ]
Pradhan, Madhulika [1 ]
Patel, Ravish J. [3 ]
Singhvi, Gautam [4 ]
Ajazuddin [5 ]
Alexander, Amit [6 ]
机构
[1] Rungta Coll Pharmaceut Sci & Res, Kohka Kurud Rd, Bhilai 490024, Chhattisgarh, India
[2] Pt Ravishankar Shukla Univ, Univ Inst Pharm, Raipur 492010, Chhattisgarh, India
[3] Charotar Univ Sci & Technol, Ramanbhai Patel Coll Pharm, CHARUSAT Campus, Anand 388421, Gujarat, India
[4] Birla Inst Technol & Sci, Dept Pharm, Pilani BITS PILANI, Pilani Campus, Pilani, Rajasthan, India
[5] SVKMs NMIMS, Dept Pharmaceut, Sch Pharm & Technol Management, Shirpur 425405, Maharashtra, India
[6] Natl Inst Pharmaceut Educ & Res NIPER Guwahati, Gauhati 781101, Assam, India
关键词
Curcumin; Nano lipid carrier; Alzheimer's disease; Box-Behnken design; Release kinetics; BRAIN DELIVERY; DRUG-DELIVERY; FORMULATION; BIOAVAILABILITY; STRATEGIES; EFFICIENCY; NOSE;
D O I
10.1016/j.biopha.2021.111919
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
100103 [病原生物学]; 100218 [急诊医学];
摘要
Herbal antioxidant like curcumin holds great potential to treat neurodegenerative disease like Alzheimer's disease. However, its therapeutic potency is obstructed due to rapid metabolism, poor solubility, GI susceptibility, enzymatic degradation and lower bioavailability. Thus, the present work aimed to design and optimize curcumin-loaded NLC (CNL) with higher drug entrapment, prolonged release and better stability. CNL was prepared by modified melt emulsification method followed by ultrasonication. The formulation was optimized by 3 factor 3 level Box-Behnken design using solid: liquid lipid, surfactant concentration and ultrasonication time as independent variable while particle size, entrapment efficiency and % drug release as dependant variable. The design suggested 3.092 solid:liquid lipid, 2.131% surfactant and 4.757 min ultrasonication fit best to get the optimized formulation. The size of the optimized CNL was noted 124.37 +/- 55.81 nm, which is in the acceptable range for brain delivery. SEM results also comply with this size range (near 150 nm) and demonstrated almost spherical and uniform particles with porous and uneven surface structures. PDI, zeta potential, entrapment efficiency and % drug release were observed as 0.201 +/- 0.00, - 17.2 +/- 2.35 mV, 93.62 +/- 0.68% and 92.73 +/- 0.06%, respectively. The NLC demonstrated initial burst release with subsequent prolonged release of drug for 48 h. Weibull kinetic equation with 0.9958 R-2, minimum AIC and maximum MSC value was found best fit to explain the release behavior. The beta exponent and diffusional coefficient (n) indicated combined release mechanism with Fickian diffusion as drug release mechanism. Formulation was also found stable at different storage condition.
引用
收藏
页数:13
相关论文
共 56 条
[1]
Superparamagnetic Iron Oxidee-Loaded Lipid Nanocarriers Incorporated in Thermosensitive In Situ Gel for Magnetic Brain Targeting of Clonazepam [J].
Abbas, Haidy ;
Refai, Hanan ;
El Sayed, Nesrine .
JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 107 (08) :2119-2127
[2]
Agrawal M., 2020, J CONTROL RELEASE, V321, P372, DOI [DOI 10.1016/J.JC0NREL.2020.02, DOI 10.1080/17425247.2018.1471058]
[3]
Biomaterials in treatment of Alzheimer's disease [J].
Agrawal, Mukta ;
Prathyusha, Eluri ;
Ahmed, Hafiz ;
Dubey, Sunil Kumar ;
Kesharwani, Prashant ;
Singhvi, Gautam ;
Naidu, V. G. M. ;
Alexander, Amit .
NEUROCHEMISTRY INTERNATIONAL, 2021, 145
[4]
Stimuli-responsive In situ gelling system for nose-to-brain drug delivery [J].
Agrawal, Mukta ;
Saraf, Shailendra ;
Saraf, Swarnlata ;
Dubey, Sunil K. ;
Puri, Anu ;
Gupta, Umesh ;
Kesharwani, Prashant ;
Ravichandiran, V ;
Kumar, Pramod ;
Naidu, V. G. M. ;
Murty, Upadhyayula Suryanarayana ;
Ajazuddin ;
Alexander, Amit .
JOURNAL OF CONTROLLED RELEASE, 2020, 327 :235-265
[5]
Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs [J].
Agrawal, Mukta ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Antimisiaris, Sophia G. ;
Chougule, Mahavir Bhupal ;
Shoyele, Sunday A. ;
Alexander, Amit .
JOURNAL OF CONTROLLED RELEASE, 2018, 281 :139-177
[6]
Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region [J].
Agrawal, Mukta ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Antimisiaris, Sophia G. ;
Hamano, Nobuhito ;
Li, Shyh-Dar ;
Chougule, Mahavir ;
Shoyele, Sunday A. ;
Gupta, Umesh ;
Ajazuddin ;
Alexander, Amit .
EXPERT OPINION ON DRUG DELIVERY, 2018, 15 (06) :589-617
[7]
Recent advancements in liposomes targeting strategies to cross blood-brain barrier (BBB) for the treatment of Alzheimer's disease [J].
Agrawal, Mukta ;
Ajazuddin ;
Tripathi, Dulal K. ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Antimisiaris, Sophia G. ;
Mourtas, Spyridon ;
Hammarlund-Udenaes, Margareta ;
Alexander, Amit .
JOURNAL OF CONTROLLED RELEASE, 2017, 260 :61-77
[8]
Ahmadi N., 2021, BRAIN RES
[9]
Formulation Strategies of Nano Lipid Carrier for Effective Brain Targeting of Anti-AD Drugs [J].
Alexander, Amit ;
Agrawal, Mukta ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Ajazuddin ;
Chougule, Mahavir B. .
CURRENT PHARMACEUTICAL DESIGN, 2020, 26 (27) :3269-3280
[10]
Recent expansions of novel strategies towards the drug targeting into the brain [J].
Alexander, Amit ;
Agrawal, Mukta ;
Uddin, Ajaz ;
Siddique, Sabahuddin ;
Shehata, Ahmed M. ;
Shaker, Mahmoud A. ;
Rahman, Syed Ata Ur ;
Abdul, Mohi Iqbal M. ;
Shaker, Mohamed A. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 :5895-5909